OraNet is our international network of more than 400 investigative sites across the US, Europe, and Asia – each one carefully selected for its strict adherence to quality standards for ophthalmic clinical trial conduct.

Our Global Ophthalmology Site Database

Working with high-quality sites results in a clinical trial that is more likely to finish on time, on budget, with minimal data variability. Every OraNet site is composed of ophthalmologists and their staff who are experienced across all ophthalmology specialties including dry eye disease, allergic conjunctivitis, glaucoma, cataract, and diseases of the retina.

All OraNet sites are required to meet the following stringent qualifications:

  • Must undergo Ora’s highly selective evaluation process that grades ophthalmology experience, skill sets, integrity, and organizational abilities.
  • Must have an unparalleled dedication to careful adherence to current Good Clinical Practice (cGCP) guidelines and requirements outlined by our Quality Compliance team.
  • Must have experienced clinical staff with a passion for excellence in ophthalmology clinical research and the diligence necessary to successfully execute a clinical trial protocol from start to finish.

Once selected, OraNet sites are extensively trained and supported by our in-house clinical trial specialists who work closely with each site to instruct investigators and staff before the start of each new protocol – as well as during the study to manage efficient trial execution and ensure protocol adherence. Access to Ora’s validated clinical models and scales standardizes study environments at OraNet sites, reduces variability among sites, and delivers more reliable clinical trial outcomes.

Site Feasibility and Selection

Ora selects sites based on the needs of your ophthalmology study. We will conduct feasibility and site selection based on your study design objectives and required patient population in order to match you with the best sites to help you meet your goals.

How We Set You Up for Success

  • Identify sites with the required patient population
  • Ensure sites are aware of all expectations
  • Confirm availability of dedicated resources
  • Work closely toward planning enrollment timeframes
  • Confirm timelines with selected sites
  • Prepare the site for the first patient first visit (FPFV) milestone
  • Facilitate site-targeted electronic medical record (EMR) database search to identify potential patients early

Retina Studies Network

Gain exclusive access to retina patients at integrated practice-based research sites in the U.S. with Ora’s retina site and patient network designed to connect investigators, sponsors and patients. Exclusive access to an established network of retina patients means we enroll the right retina patient in the right trial at the right time for meaningful results.

Our retina network sites are located throughout the United States, integrated within thriving retina practices in cities with a high prevalence of people with age related macular degeneration and diabetic retina diseases. We’re invested in maintaining exclusive partnerships and close relationships with our network of sites and share a commitment to the highest standards of clinical research to deliver quality results.

Contact Us to Learn More